Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIV Immune Response in HIV and/or TB Adults
NCT01811823Phase 4Completed
- Sponsor
- University of the Witwatersrand
- Start
- Mar 2014
- Primary completion
- Nov 2014
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of influenza vaccine in influenza (4 arms), sponsored by University of the Witwatersrand. Primary endpoint: Humoral antibody responses measured by hemagglutinin inhibition assay at 6 weeks. Started Mar 2014; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01811823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01811823.